Intellia Therapeutics Inc...
(NTLA)
undefined
undefined%
At close: undefined
12.94
0.35%
After-hours Dec 13, 2024, 07:22 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
| Net Income | -481.19M | -474.19M | -267.89M | -134.23M | -99.53M | -85.34M | -67.54M | -31.63M | -12.40M | -14.31M |
| Depreciation & Amortization | 8.98M | 7.57M | 6.89M | 6.31M | 5.59M | 4.46M | 2.99M | 1.10M | 328.00K | 4.50K |
| Stock-Based Compensation | 134.05M | 91.40M | 47.01M | 19.90M | 15.09M | 17.05M | 15.32M | 6.71M | 1.31M | 462.00K |
| Other Working Capital | -2.78M | -47.55M | -31.36M | 45.12M | -27.12M | -3.94M | -12.99M | 67.97M | 9.67M | 1.03M |
| Other Non-Cash Items | -3.47M | 95.80M | 2.94M | 573.00K | -3.72M | -601.00K | 166.00K | 6.71M | 9.00K | 9.33M |
| Deferred Income Tax | - | - | 8.93M | - | - | - | - | -6.70M | -1.01M | - |
| Change in Working Capital | -52.45M | -53.87M | -22.90M | 57.53M | -20.66M | 3.18M | -16.21M | 59.91M | 10.00M | 1.03M |
| Operating Cash Flow | -394.09M | -333.29M | -225.03M | -49.91M | -103.24M | -61.26M | -65.28M | 36.11M | -1.76M | -3.48M |
| Capital Expenditures | -13.98M | -58.39M | -12.76M | -3.58M | -6.79M | -6.36M | -10.09M | -6.17M | -2.55M | -412.50K |
| Acquisitions | - | -44.68M | -3.00M | 210.90M | -31.97M | 131.00K | - | - | - | - |
| Purchase of Investments | -904.46M | -429.03M | -1.02B | -473.70M | -297.03M | -254.56M | - | - | - | - |
| Sales Maturities Of Investments | 887.10M | 647.58M | 485.60M | 262.80M | 329.00M | - | - | - | - | - |
| Other Investing Acitivies | - | 44.83M | -538.02M | -210.90M | 31.97M | 131.00K | -10.10K | - | - | -450.00K |
| Investing Cash Flow | -31.35M | 160.31M | -550.78M | -214.49M | 25.18M | -260.78M | -10.09M | -6.17M | -2.55M | -862.50K |
| Debt Repayment | - | - | - | - | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - | - | - | -2.67M | - |
| Dividend Paid | - | - | - | - | - | - | - | - | - | - |
| Other Financial Acitivies | 10.53M | 17.17M | 43.12M | 13.13M | 4.18M | 11.67M | 1.98M | -3.20M | 70.29M | 19.11M |
| Financial Cash Flow | 130.32M | 582.96M | 736.69M | 371.78M | 76.43M | 40.22M | 142.98M | 167.30M | 70.29M | 19.11M |
| Net Cash Flow | -295.11M | 409.98M | -39.12M | 107.38M | -1.63M | -281.82M | 67.61M | 197.25M | 65.97M | 14.77M |
| Free Cash Flow | -408.07M | -391.68M | -237.79M | -53.50M | -110.03M | -67.61M | -75.37M | 29.94M | -4.32M | -3.90M |